ZEB1 and central nervous system cancer: What was significant with this study was the realization of 3 key components 1) it was necessary to study raw copy number data where heterozygous deletions are more readily identified as opposed to the normal typical analyses of data, thereby explaining the discordance of previous studies that had not revealed decreased expression or loss of ZEB1 in gliomas.